“…Depending on the etiology, IS have been classified into structural/metabolic, genetic, and etiologyunknown [2]. More than 200 possible causes have been described but the majority of IS are linked to pre-existing structural/metabolic brain pathologies such as cortical dysplasia, tuberous sclerosis complex, known metabolic disorders, and hypoxic/ischemic brain damage [1,3]. These structural/metabolic IS are frequently refractory to conventional therapies including adrenocorticotropic hormone (ACTH) and vigabatrin, although studies have suggested that successful initial treatment with these drugs results in better epilepsy and cognitive outcome in the etiologyunknown subgroup [4,5].…”